MA31675B1 - Petites molecules contenant du bore - Google Patents

Petites molecules contenant du bore

Info

Publication number
MA31675B1
MA31675B1 MA32517A MA32517A MA31675B1 MA 31675 B1 MA31675 B1 MA 31675B1 MA 32517 A MA32517 A MA 32517A MA 32517 A MA32517 A MA 32517A MA 31675 B1 MA31675 B1 MA 31675B1
Authority
MA
Morocco
Prior art keywords
small molecules
molecules containing
containing boron
compounds
things
Prior art date
Application number
MA32517A
Other languages
Arabic (ar)
English (en)
Inventor
Stephen J Baker
Vincent S Hernandez
Rashmi Sharma
James A Nieman
Tsutoma Akama
Yong-Kang Zhang
Jacob J Plattner
Michael Richard Kevin Alley
Rajeshwar Singh
Yi Xia
Huchen Zhou
Rahim Mohammad
El Mehdi Keramane
Xiaosong Lu
Minh Ha
James G Phillips
Original Assignee
Anacor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40156702&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA31675(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Anacor Pharmaceuticals Inc filed Critical Anacor Pharmaceuticals Inc
Publication of MA31675B1 publication Critical patent/MA31675B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L'INVENTION CONCERNE, ENTRE AUTRES CHOSES, DE NOUVEAUX COMPOSÉS UTILES POUR TRAITER DES INFECTIONS BACTÉRIENNES, DES COMPOSITIONS PHARMACEUTIQUES CONTENANT DE TELS COMPOSÉS AINSI QUE DES COMBINAISONS DE CES COMPOSÉS RENFERMANT AU MOINS UN AGENT SUPPLÉMENTAIRE THÉRAPEUTIQUEMENT EFFICACE.
MA32517A 2007-06-20 2010-01-15 Petites molecules contenant du bore MA31675B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94529407P 2007-06-20 2007-06-20
US4117808P 2008-03-31 2008-03-31
PCT/US2008/067550 WO2008157726A1 (fr) 2007-06-20 2008-06-19 Petites molécules contenant du bore

Publications (1)

Publication Number Publication Date
MA31675B1 true MA31675B1 (fr) 2010-09-01

Family

ID=40156702

Family Applications (1)

Application Number Title Priority Date Filing Date
MA32517A MA31675B1 (fr) 2007-06-20 2010-01-15 Petites molecules contenant du bore

Country Status (29)

Country Link
US (4) US7816344B2 (fr)
EP (1) EP2164331B1 (fr)
JP (3) JP5530923B2 (fr)
KR (3) KR101685656B1 (fr)
CN (2) CN104017008A (fr)
AR (1) AR067105A1 (fr)
AU (1) AU2008265630B2 (fr)
BR (1) BRPI0813450B8 (fr)
CA (1) CA2692135C (fr)
CL (1) CL2008001855A1 (fr)
CO (1) CO6251209A2 (fr)
CR (1) CR11224A (fr)
DK (1) DK2164331T3 (fr)
DO (1) DOP2009000281A (fr)
EA (1) EA020530B1 (fr)
ES (1) ES2655299T3 (fr)
IL (1) IL202379A (fr)
JO (1) JO3396B1 (fr)
MA (1) MA31675B1 (fr)
MX (1) MX347688B (fr)
MY (1) MY162692A (fr)
NO (1) NO2164331T3 (fr)
NZ (1) NZ582706A (fr)
PE (1) PE20090840A1 (fr)
SG (1) SG182219A1 (fr)
TW (1) TW200911822A (fr)
UY (1) UY31171A1 (fr)
WO (1) WO2008157726A1 (fr)
ZA (2) ZA200909003B (fr)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ578297A (en) * 2005-02-16 2010-11-26 Anacor Pharmaceuticals Inc Boron-containing small molecules
EP1976536A4 (fr) 2005-12-30 2011-03-02 Anacor Pharmaceuticals Inc Petites molecules contenant du bore
ME02188B (me) 2006-02-16 2016-02-20 Anacor Pharmaceuticals Inc Mali molekuli koji sadrže boron kao antiinflamatorni agensi
CA2651212A1 (fr) 2006-05-02 2007-11-15 Anacor Pharmaceuticals, Inc. Substances therapeutiques contenant du bore resistant a l'hydrolyse et methodes d'utilisation
JO3396B1 (ar) * 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
CN102014927A (zh) 2008-03-06 2011-04-13 安纳考尔医药公司 作为抗炎药的含硼的小分子
WO2009140309A2 (fr) * 2008-05-12 2009-11-19 Anacor Pharmaceuticals, Inc. Petites molécules contenant du bore
WO2010027975A1 (fr) 2008-09-04 2010-03-11 Anacor Pharmaceuticals, Inc. Petites molécules contenant du bore
US8461336B2 (en) 2008-09-04 2013-06-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US9493489B2 (en) * 2008-10-15 2016-11-15 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents
MX2011006334A (es) * 2008-12-17 2011-09-22 Anacor Pharmaceuticals Inc Polimorfos de (s)-3-amino-metil-7-(3-hidroxi-propoxi)-3h-benzo-[c] [1,2]-oxaborol-1-ol.
WO2010132833A1 (fr) * 2009-05-14 2010-11-18 The Regents Of The University Of Michigan Compositions vaccinales contre streptococcus et méthodes d'utilisation associées
WO2011017125A1 (fr) * 2009-07-28 2011-02-10 Anacor Pharmaceuticals, Inc. Molécules contenant du bore trisubstitué
WO2011019616A1 (fr) 2009-08-14 2011-02-17 Anacor Pharmaceuticals, Inc. Petites molécules contenant du bore à titre d'agents anti-protozoaires
AP4039A (en) 2009-08-14 2017-02-28 Daitao Chen Boron-containing small molecules as antiprotozoal agents
WO2011019612A1 (fr) 2009-08-14 2011-02-17 Anacor Pharmaceuticals, Inc. Petites molécules contenant du bore en tant qu'agents antiprotozoaires
WO2011022337A1 (fr) * 2009-08-19 2011-02-24 Anacor Pharmaceuticals, Inc. Petites molécules contenant du bore en tant qu'agents anti-protozoaires
US20110124597A1 (en) * 2009-09-25 2011-05-26 Anacor Pharmaceuticals, Inc. Boron containing small molecules
US8979820B2 (en) 2009-10-09 2015-03-17 Cynthia S. Bailey Method and apparatus for improving the appearance of nails affected by onychomycosis through the topical application of an aqueous solution containing boric acid and camphor or other terpenes
WO2011049971A1 (fr) 2009-10-20 2011-04-28 Anacor Pharmaceuticals, Inc. Petites molécules contenant du bore comme agents antiprotozoaires
US8461134B2 (en) * 2009-11-11 2013-06-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US8716478B2 (en) 2010-01-27 2014-05-06 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2011116348A1 (fr) 2010-03-19 2011-09-22 Anacor Pharmaceuticals, Inc. Petites molécules borées en tant qu'agent anti-protozoaire
MX352607B (es) * 2010-04-07 2017-11-30 Glaxosmithkline Llc Star Proceso para la preparacion de benzoxaboroles.
WO2012033858A2 (fr) * 2010-09-07 2012-03-15 Anacor Pharmaceuticals, Inc. Petites molécules contenant du bore
WO2013025975A1 (fr) * 2011-08-17 2013-02-21 Glaxosmithkline Llc Traitements combinés pour l'hépatite c
WO2013049424A1 (fr) 2011-09-28 2013-04-04 Wisconsin Alumni Research Foundation Conversion catalytique de la cellulose en carburants et en produits chimiques avec des acides boroniques
AR088668A1 (es) 2011-11-21 2014-06-25 Lilly Co Eli Moleculas pequeñas que contienen boro
AR088669A1 (es) 2011-11-21 2014-06-25 Lilly Co Eli Derivados de dihidrodibenzo[c][1,2]oxaborol y dihidroisoxazol utiles para el control de ectoparasitos
US8530452B2 (en) 2011-12-22 2013-09-10 Micurx Pharmaceuticals, Inc. Tricyclic boron compounds for antimicrobial therapy
US20150080342A1 (en) * 2012-04-14 2015-03-19 Anacor Pharmaceuticals, Inc. Benzoxaborole compounds and uses thereof
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
US9138001B2 (en) 2013-01-30 2015-09-22 Agrofresh Inc. Use of benzoxaboroles as volatile antimicrobial agents on meats, plants, or plant parts
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
WO2014121124A1 (fr) 2013-02-01 2014-08-07 Anacor Pharmaceuticals, Inc. Molécules de petite taille contenant du bore en qualité d'agents anti-protozoaires
AU2014202928B1 (en) * 2013-06-05 2014-09-11 Agrofresh Inc. Compounds and compositions
KR101636431B1 (ko) * 2013-07-30 2016-07-05 동아에스티 주식회사 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
EA032844B1 (ru) 2013-08-09 2019-07-31 Глаксосмитклайн Интеллекчуал Проперти (№2) Лимитед Трициклические соединения бензоксаборола и их применение
EA038093B1 (ru) * 2013-12-20 2021-07-05 Глаксосмитклайн Интеллекчуал Проперти (№2) Лимитед Способ лечения заболевания, вызванного инфекцией комплекса mycobacterium tuberculosis, с использованием (s)-(3-хлор-7,8-дигидро-2h-1,6,9-триокса-9a-борабензо[cd]азулен-2-ил)метанамина или его фармацевтически приемлемой соли
WO2015121442A1 (fr) * 2014-02-17 2015-08-20 Syngenta Participations Ag Benzoxaboroles à effet microbiocide
JP6605513B2 (ja) * 2014-07-01 2019-11-13 第一三共株式会社 抗菌剤としての三環式ベンゾオキサボロール
US9738664B2 (en) * 2014-10-29 2017-08-22 Wisconsin Alumni Research Foundation Boronic acid inhibitors of HIV protease
MA41494B1 (fr) * 2015-02-12 2020-10-28 Glaxosmithkline Ip No 2 Ltd Composés benzoxaborole substitués en position 4 et utilisations associées
CN107872956B (zh) 2015-04-09 2020-07-10 宾夕法尼亚州研究基金会 含有苯并氧杂硼戊环的协同性抗真菌组合物
WO2017024022A1 (fr) * 2015-08-06 2017-02-09 The Penn State Research Foundation Revêtement contenant du benzoxaborole résistant à un champignon susceptible d'être porté par la cellulose
CN113563368A (zh) 2016-03-02 2021-10-29 比尔及梅琳达盖茨基金会 含硼小分子
US10874679B2 (en) 2016-03-02 2020-12-29 Bill & Melinda Gates Foundation Boron-containing small molecules
WO2017151492A1 (fr) 2016-03-02 2017-09-08 Anacor Pharmaceuticals, Inc. Petites molécules contenant du bore
WO2017155879A1 (fr) 2016-03-07 2017-09-14 Agrofresh Inc. Procédés synergiques d'utilisation de composés de benzoxaborole et de gaz de conservation en tant qu'agent antimicrobien pour les plantes cultivées
UA121354C2 (uk) 2016-05-12 2020-05-12 Анакор Фармасутікалз, Інк. Нові сполуки для лікування паразитарних захворювань
US10961261B2 (en) 2017-03-01 2021-03-30 Anacor Pharmaceuticals, Inc. Oxaborole analogs and uses thereof
CN107090000B (zh) * 2017-04-27 2019-07-12 上海交通大学 一种苯并硼唑7位脂肪酸的衍生物及其制备与用途
EP4265332B1 (fr) * 2017-06-13 2025-02-19 Veterinary Diagnostics Institute, Inc. Système et procédure pour stabiliser, stocker et récupérer des échantillons de sang
CA3120974A1 (fr) * 2017-11-30 2019-06-06 Boragen, Inc. Compositions combinatoires de benzoxaboroles et d'agents biologiques
US11834466B2 (en) 2017-11-30 2023-12-05 5Metis, Inc. Benzoxaborole compounds and formulations thereof
US11236115B2 (en) 2018-08-18 2022-02-01 5Metis, Inc. Solid forms of substituted benzoxaborole and compositions thereof
WO2020051575A1 (fr) * 2018-09-07 2020-03-12 Boragen, Inc. Composés contenant du bore et leurs utilisations
US11058695B2 (en) * 2019-11-08 2021-07-13 Myongji University Industry And Academia Cooperation Foundation Inhibitor of carbapenem-hydrolyzing class D beta-lactamases
EP4204012A1 (fr) 2020-08-31 2023-07-05 Pfizer Inc. Procédés de protection de l'arn
CN119233977B (zh) * 2022-06-23 2026-03-17 上海盟科药业股份有限公司 硼化合物的前药及其在治疗细菌感染中的用途
AU2023287202A1 (en) * 2022-06-23 2024-06-06 Shanghai Micurx Pharmaceutical Co., Ltd. Methods and uses of boron compounds in the treatment of nontuberculous mycobacterium infections and pharmaceutical compositions for treatment of same
US12482208B2 (en) 2023-05-30 2025-11-25 Snap Inc. Mirroring 3D assets for virtual experiences

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2260336A (en) * 1939-10-16 1941-10-28 Dow Chemical Co Method of preparation of organic borates
GB1396904A (en) * 1972-08-11 1975-06-11 Ici Ltd Method for the control of micro-organisms
US5962498A (en) * 1986-06-11 1999-10-05 Procyon Pharmaceuticals, Inc. Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity
US4919934A (en) 1989-03-02 1990-04-24 Richardson-Vicks Inc. Cosmetic sticks
US5594151A (en) * 1994-01-28 1997-01-14 Prolinx, Inc. Phenylboronic acid complexing reagents derived from aminosalicylic acid
GB9411587D0 (en) * 1994-06-09 1994-08-03 Zeneca Ltd Compound, composition and use
US6083903A (en) * 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
US5831046A (en) * 1996-08-05 1998-11-03 Prolinx, Incorporated Boronic acid-contaning nucleic acid monomers
US6306628B1 (en) * 1999-08-25 2001-10-23 Ambergen, Incorporated Methods for the detection, analysis and isolation of Nascent proteins
AU7995300A (en) * 1999-10-05 2001-05-10 Bethesda Pharmaceuticals, Inc. Dithiolane derivatives
WO2002006316A2 (fr) * 2000-07-14 2002-01-24 Zycos, Inc. Composes en rapport avec $g(a)-msh et methodes d'utilisation
US6537733B2 (en) * 2001-02-23 2003-03-25 Applied Materials, Inc. Method of depositing low dielectric constant silicon carbide layers
GB0117645D0 (en) * 2001-07-19 2001-09-12 Isis Innovation Therapeutic stratergies for prevention and treatment of alzheimers disease
DE10143979A1 (de) 2001-09-07 2003-03-27 Clariant Gmbh Verfahren zur Herstellung von Bisallylboranen und nicht-aromatischen Boronsäuren
EP1444981A1 (fr) * 2001-10-11 2004-08-11 Katsuhiko Mikoshiba Inhibiteurs de l'augmentation de la concentration du calcium intracellulaire
JP4138662B2 (ja) 2002-01-10 2008-08-27 ザ・ペンシルバニア・ステイト・リサーチ・フアウンデイシヨン アルキルジアリールボリネートおよび錯化ジアリールボロン酸を調製するための方法。
HRP20041220A2 (hr) * 2002-05-28 2006-04-30 3-Dimensional Pharmaceuticals Novi tiofen amidini, njihovi pripravci i postupci liječenja komplementom posredovanih bolesti i stanja
AU2004262524C1 (en) * 2003-06-16 2010-08-19 Anacor Pharmaceuticals, Inc. Hydrolytically-resistant boron-containing therapeutics and methods of use
KR101300929B1 (ko) * 2004-05-12 2013-08-27 더 브리검 앤드 우먼즈 하스피털, 인크. 감염 치료를 위한 겔솔린의 용도
NZ578297A (en) * 2005-02-16 2010-11-26 Anacor Pharmaceuticals Inc Boron-containing small molecules
EP1976536A4 (fr) 2005-12-30 2011-03-02 Anacor Pharmaceuticals Inc Petites molecules contenant du bore
ME02188B (me) * 2006-02-16 2016-02-20 Anacor Pharmaceuticals Inc Mali molekuli koji sadrže boron kao antiinflamatorni agensi
RU2008152367A (ru) * 2006-06-12 2010-07-20 Анакор Фармасьютикалз, Инк. (Us) Соединения для лечения периодонтального заболевания
US20070286822A1 (en) * 2006-06-12 2007-12-13 Anacor Pharmaceuticals Inc. Compounds for the Treatment of Periodontal Disease
DE102006038471A1 (de) 2006-08-17 2008-04-10 Wala-Heilmittel Gmbh Platanencreme, Verfahren zu ihrer Herstellung und Verwendung
JO3396B1 (ar) * 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
WO2009140309A2 (fr) * 2008-05-12 2009-11-19 Anacor Pharmaceuticals, Inc. Petites molécules contenant du bore

Also Published As

Publication number Publication date
KR20160049025A (ko) 2016-05-04
IL202379A (en) 2016-02-29
TW200911822A (en) 2009-03-16
JP2010530881A (ja) 2010-09-16
UY31171A1 (es) 2009-04-30
US8895534B2 (en) 2014-11-25
US7816344B2 (en) 2010-10-19
WO2008157726A1 (fr) 2008-12-24
NZ582706A (en) 2012-07-27
MY162692A (en) 2017-07-14
JP6570391B2 (ja) 2019-09-04
CN104017008A (zh) 2014-09-03
CL2008001855A1 (es) 2009-05-29
ZA201104573B (en) 2014-03-26
CO6251209A2 (es) 2011-02-21
CA2692135C (fr) 2017-01-24
JP5530923B2 (ja) 2014-06-25
IL202379A0 (en) 2010-06-30
SG182219A1 (en) 2012-07-30
AU2008265630B2 (en) 2013-06-20
CN101772302B (zh) 2014-05-07
KR20150100945A (ko) 2015-09-02
US10533021B2 (en) 2020-01-14
CA2692135A1 (fr) 2008-12-24
US20100292504A1 (en) 2010-11-18
BRPI0813450B1 (pt) 2019-05-07
PE20090840A1 (es) 2009-07-08
BRPI0813450B8 (pt) 2021-05-25
CR11224A (es) 2010-06-28
EP2164331B1 (fr) 2017-11-29
MX347688B (es) 2017-05-09
AU2008265630A1 (en) 2008-12-24
US20180016285A1 (en) 2018-01-18
ZA200909003B (en) 2022-03-30
DK2164331T3 (da) 2018-01-29
US20150133402A1 (en) 2015-05-14
JP2016040275A (ja) 2016-03-24
ES2655299T3 (es) 2018-02-19
US9796735B2 (en) 2017-10-24
KR101578351B1 (ko) 2015-12-17
JP2014148531A (ja) 2014-08-21
US20090227541A1 (en) 2009-09-10
EP2164331A1 (fr) 2010-03-24
BRPI0813450A2 (pt) 2014-12-30
CN101772302A (zh) 2010-07-07
NO2164331T3 (fr) 2018-04-28
AR067105A1 (es) 2009-09-30
KR20100051615A (ko) 2010-05-17
EA200901617A1 (ru) 2010-06-30
DOP2009000281A (es) 2010-07-31
EA020530B1 (ru) 2014-11-28
KR101685656B1 (ko) 2016-12-12
EP2164331A4 (fr) 2011-09-07
JO3396B1 (ar) 2019-10-20

Similar Documents

Publication Publication Date Title
MA31675B1 (fr) Petites molecules contenant du bore
MA32104B1 (fr) Dérivés d'oxime en tant qu'inhibiteurs de hsp90
MY157928A (en) Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
MA31167B1 (fr) Inhibiteurs de l'activite de akt
PE20081506A1 (es) Formulaciones de ansamicina
MA31683B1 (fr) Composes et procedes pour moduler fxr
BRPI0609121B8 (pt) 1h-benzimidazol-4-carboxamidas substituídas com um carbono quaternário na posição 2
MA30872B1 (fr) Compositions d'inhibiteurs de la chk1.
EA200900828A1 (ru) Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1
EA200901166A1 (ru) Соединения и композиции в качестве модуляторов активности gpr 119
MX2012002031A (es) Moleculas pequeñas que contienen boro como agentes antiprotozoarios.
MA31928B1 (fr) Micro-organismes, fertilisants de phosphate microbien et procédés de préparation de ces fertilisants de phosphate microbien
WO2010027975A8 (fr) Petites molécules contenant du bore
ATE433980T1 (de) Gyraseinhibitoren und deren verwendungen
MA30358B1 (fr) Quinazolines pour l'inhibition de pdk1
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
DK1948155T3 (da) Farmaceutiske præparater omfattende droxidopa
MA30912B1 (fr) Nouveaux derives de phenylsulfamoyl-benzamide en tant qu'antagonistes de la bradykinine
EP2091328A4 (fr) Composés de spiropipéridine inhibiteurs de la bêta-sécrétase pour le traitement de la maladie d'alzheimer
WO2009038842A3 (fr) Procédés et compositions pour inhiber le facteur d'œdème et l'adénylylcyclase
TW200734344A (en) Antibacterial agents
CL2009002129A1 (es) Derivados carboxiamida de lantibioticos; proceso de preparacion de dichos lantibioticos; composicion farmaceutica que lo contiene; utiles en el tratamiento de infecciones bacterianas.
FR2940063B1 (fr) Compositions anti-transpirantes contenant au moins un complexe forme par l'association d'au moins une espece anionique et d'au moins une espece cationique et procede de traitement de la transpiration humaine.
MA32061B1 (fr) Triazolopyridazines en tant qu'inhibiteurs de par1, production de celles-ci, et utilisation en tant que médicaments
DE60317935D1 (de) Alpha-aminoamid-derivate als mittel gegen migräne